Systematic screening of promoter regions pinpoints functional cis-regulatory mutations in a cutaneous melanoma genome

Molecular Cancer Research

Volumn 13, Issue 8, 2015, Pages 1218-1226

  Poulos, Rebecca C ^a,b   Thoms, Julie A I ^a,b   Shah, Anushi ^a,b   Beck, Dominik ^a,b   Pimanda, John E ^a,b,c   Wong, Jason W H ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; HISTONE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); TRANSCRIPTION FACTOR SP1; CHROMATIN; NDUFB9 PROTEIN, HUMAN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE;

5' UNTRANSLATED REGION; ALGORITHM; ARTICLE; CONTROLLED STUDY; CUTANEOUS MELANOMA; EXOME; GENE FREQUENCY; GENE IDENTIFICATION; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; GENETIC SCREENING; HISTONE MODIFICATION; HUMAN; HUMAN CELL; HUMAN GENOME; MELANOCYTE; MELANOMA CELL LINE; MUTATION RATE; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; WILD TYPE; BIOLOGICAL MODEL; CHROMATIN; GENETIC PROCEDURES; GENETIC TRANSCRIPTION; GENETICS; MELANOMA; METABOLISM; MUTATION; REGULATORY SEQUENCE; REPORTER GENE; SKIN TUMOR; TUMOR CELL LINE;

CELL LINE, TUMOR; CHROMATIN; GENES, REPORTER; GENETIC TECHNIQUES; GENOME, HUMAN; HUMANS; MELANOMA; MODELS, GENETIC; MUTATION; NADH DEHYDROGENASE; PROMOTER REGIONS, GENETIC; REGULATORY ELEMENTS, TRANSCRIPTIONAL; SKIN NEOPLASMS; SP1 TRANSCRIPTION FACTOR; TRANSCRIPTION, GENETIC;

EID: 84942413006     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-15-0146     Document Type: Article

References (41)

1. Nowell PC. The clonal evolution of tumor cell populations. Science 1976;194:23-8.
2. Mardis ER, Ding L, Dooling DJ, Larson DE, McLellan MD, Chen K, et al. Recurring mutations found by sequencing an acute myeloid leukemia genome. N Engl J Med 2009;361:1058-66.
3. Timmermann B, Kerick M, Roehr C, Fischer A, Isau M, Boerno ST, et al. Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis. PLoS ONE 2010;5:e15661.
4. Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature 2007;446:153-8.
5. Supek F, Miñana B, Valcárcel J, Gabaldón T, Lehner B. Synonymous mutations frequently act as drivermutations in human cancers. Cell 2014;156:1324-35.
6. Huang FW, Hodis E, Xu MJ, Kryukov GV, Chin L, Garraway LA. Highly recurrent TERT promoter mutations in human melanoma. Science 2013;339:957-9.
7. Vinagre J, Almeida A, Populo H, Batista R, Lyra J, Pinto V, et al. Frequency of TERT promoter mutations in human cancers. Nat Commun 2013;4:2185.
8. MacConaill LE, Garraway LA. Clinical implications of the cancer genome. J Clin Oncol 2010;28:5219-28.
9. Alexandrov LB, Nik-Zainal S, Wedge DC, Aparicio SA, Behjati S, Biankin AV, et al. Signatures of mutational processes in human cancer. Nature 2013;500:415-21.
10. Schweiger MR, Barmeyer C, Timmermann B. Genomics and epigenomics: new promises of personalized medicine for cancer patients. Brief Funct Genomics 2013;12:411-21.
11. Vogelstein B, Papadopoulos N, Velculescu VE, Zhou S, Diaz LA Jr Kinzler KW. Cancer genome landscapes. Science 2013;339:1546-58.
12. Zhang J, Baran J, Cros A, Guberman JM, Haider S, Hsu J, et al. International Cancer Genome Consortium Data Portal - A one-stop shop for cancer genomics data. Database 2011;19.
13. Weinhold N, Jacobsen A, Schultz N, Sander C, Lee W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat Genet 2014;28:1160-5.
14. Fredriksson NJ, Ny L, Nilsson JA, Larsson E. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat Genet 2014;46:1258-63.
15. Perera D, Chacon D, Thoms J, Poulos RC, Shlien A, Beck D, et al. OncoCis: annotation of cis-regulatory mutations in cancer. Genome Biol 2014;15:485.
16. Fu Y, Liu Z, Lou S, Bedford J, Mu X, Yip KY, et al. FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer. Genome Biol 2014;15:480.
17. Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res 2012;22:1790-7.
18. Shihab HA, Rogers MF, Gough J, Mort M, Cooper DN, Day IN, et al. An integrative approach to predicting the functional effects of non-coding and coding sequence variation. Bioinformatics 2015;31:1536-43.
19. Pleasance ED, Cheetham RK, Stephens PJ, McBride DJ, Humphray SJ, Greenman CD, et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 2010;463:191-6.
20. Bamford S, Dawson E, Forbes S, Clements J, Pettett R, Dogan A, et al. The COSMIC (Catalogue of Somatic Mutations in Cancer) database and website. Br J Cancer 2004;91:355-8.
21. Forbes SA, Bindal N, Bamford S, Cole C, Kok CY, Beare D, et al. COSMIC: mining complete cancer genomes in the Catalogue of Somatic Mutations in Cancer. Nucleic Acids Res 2011;39:D945-50.
22. Saunders CT, Wong WS, Swamy S, Becq J, Murray LJ, Cheetham RK. Strelka: accurate somatic small-variant calling from sequenced tumor-normal sample pairs. Bioinformatics 2012;28:1811-7.
23. Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence Alignment/Map format and SAMtools. Bioinformatics 2009;25:2078-9.
24. ENCODE Project Consortium. The ENCODE (ENCyclopedia Of DNA Elements) Project. Science 2004;306:636-40.
25. Zhou X, Maricque B, Xie M, Li D, Sundaram V, Martin EA, et al. The Human Epigenome Browser at Washington University. Nat Methods 2011;8:989-90.
26. Barski A, Cuddapah S, Cui K, Roh TY, Schones DE, Wang Z, et al. Highresolution profiling of histone methylations in the human genome. Cell 2007;129:823-37.
27. Pruitt KD, Brown GR, Hiatt SM, Thibaud-Nissen F, Astashyn A, Ermolaeva O, et al. RefSeq: an update on mammalian reference sequences. Nucleic Acids Res 2014;42:19.
28. Lawrence MS, Stojanov P, Polak P, Kryukov GV, Cibulskis K, Sivachenko A, et al. Mutational heterogeneity in cancer and the search for new cancerassociated genes. Nature 2013;499:214-8.
29. Siepel A, Bejerano G, Pedersen JS, Hinrichs AS, Hou M, Rosenbloom K, et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res 2005;15:1034-50.
30. Mathelier A, Zhao X, Zhang AW, Parcy F, Worsley-Hunt R, Arenillas DJ, et al. JASPAR2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res 2014;42:D142-7.
31. Parmenter TJ, Kleinschmidt M, Kinross KM, Bond ST, Li J, Kaadige MR, et al. Response of BRAF-mutant melanoma to BRAF inhibition is mediated by a network of transcriptional regulators of glycolysis. Cancer Discov 2014;4:423-33.
32. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat JP, et al. A landscape of driver mutations in melanoma. Cell 2012;150:251-63.
33. The FANTOM Consortium and the RIKEN PMI and CLST. A promoter-level mammalian expression atlas. Nature 2014;507:462-70.
34. Polak P, Lawrence MS, Haugen E, Stoletzki N, Stojanov P, Thurman RE, et al. Reduced local mutation density in regulatory DNA of cancer genomes is linked to DNA repair. Nat Biotechnol 2014;32:71-5.
35. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, Kim S, et al. The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 2012;483:603-7.
36. Guo Y, Long J, He J, Li CI, Cai Q, Shu XO, et al. Exome sequencing generates high quality data in non-target regions. BMC Genomics 2012;13:194.
37. Kaczynski J, Cook T, Urrutia R. Sp1- and Kruppel-like transcription factors. Genome Biol 2003;4:206.
38. Nissan MH, Pratilas CA, Jones AM, Ramirez R, Won H, Liu C, et al. Loss of NF1 in cutaneous melanoma is associated with RAS activation and MEK dependence. Cancer Res 2014;74:2340-50.
39. Maertens O, Johnson B, Hollstein P, Frederick DT, Cooper ZA, Messiaen L, et al. Elucidating distinct roles for NF1 in melanomagenesis. Cancer Discov 2013;3:338-49.
40. Choi W, Miyamura Y, Wolber R, Smuda C, Reinhold W, Liu H, et al. Regulation of human skin pigmentation in situ by repetitive UV exposure: molecular characterization of responses to UVA and/or UVB. J Invest Dermatol 2010;130:1685-96.
41. Krzywinski M, Schein J, Birol I, Connors J, Gascoyne R, Horsman D, et al. Circos: an information aesthetic for comparative genomics. Genome research 2009;19:1639-45.